Pillay D - Search Results

1

Evidence of Self-Sustaining Drug Resistant HIV-1 Lineages Among Untreated Patients in the United Kingdom.

Mbisa JL, Fearnhill E, Dunn DT, Pillay D, Asboe D, Cane PA; UK HIV Drug Resistance Database. Mbisa JL, et al. Among authors: pillay d. Clin Infect Dis. 2015 Sep 1;61(5):829-36. doi: 10.1093/cid/civ393. Epub 2015 May 19. Clin Infect Dis. 2015. PMID: 25991470

2

The effects of antiretroviral therapy on HIV-1 RNA loads in seminal plasma in HIV-positive patients with and without urethritis.

Sadiq ST, Taylor S, Kaye S, Bennett J, Johnstone R, Byrne P, Copas AJ, Drake SM, Pillay D, Weller I. Sadiq ST, et al. Among authors: pillay d. AIDS. 2002 Jan 25;16(2):219-25. doi: 10.1097/00002030-200201250-00011. AIDS. 2002. PMID: 11807306

3

Minimal variation in T-20 binding domain of different HIV-1 subtypes from antiretroviral-naive and -experienced patients.

Xu L, Hué S, Taylor S, Ratcliffe D, Workman JA, Jackson S, Cane PA, Pillay D. Xu L, et al. Among authors: pillay d. AIDS. 2002 Aug 16;16(12):1684-6. doi: 10.1097/00002030-200208160-00016. AIDS. 2002. PMID: 12172092

4

The prevalence and determinants of the K65R mutation in HIV-1 reverse transcriptase in tenofovir-naive patients.

Winston A, Mandalia S, Pillay D, Gazzard B, Pozniak A. Winston A, et al. Among authors: pillay d. AIDS. 2002 Oct 18;16(15):2087-9. doi: 10.1097/00002030-200210180-00018. AIDS. 2002. PMID: 12370512

5

Analysis of HIV-1 variation in blood and semen during treatment and treatment interruption.

Choudhury B, Pillay D, Taylor S, Cane PA. Choudhury B, et al. Among authors: pillay d. J Med Virol. 2002 Dec;68(4):467-72. doi: 10.1002/jmv.10247. J Med Virol. 2002. PMID: 12376952

6

Evolution of antiretroviral phenotypic and genotypic drug resistance in antiretroviral-naive HIV-1-infected children treated with abacavir/lamivudine, zidovudine/lamivudine or abacavir/zidovudine, with or without nelfinavir (the PENTA 5 trial).

Gibb DM, Walker AS, Kaye S, De Rossi A, Ait-Khaled M, Pillay D, Muñoz-Fernandez MA, Loveday C, Compagnucci A, Dunn DT, Babiker AG. Gibb DM, et al. Among authors: pillay d. Antivir Ther. 2002 Dec;7(4):293-303. Antivir Ther. 2002. PMID: 12553485 Clinical Trial.

7

Identification of a transmission chain of HIV type 1 containing drug resistance-associated mutations.

Taylor S, Cane P, Hué S, Xu L, Wrin T, Lie Y, Hellmann N, Petropoulos C, Workman J, Ratcliffe D, Choudhury B, Pillay D. Taylor S, et al. Among authors: pillay d. AIDS Res Hum Retroviruses. 2003 May;19(5):353-61. doi: 10.1089/088922203765551700. AIDS Res Hum Retroviruses. 2003. PMID: 12803994

8

Drug resistance genotypes predict response to amprenavir-containing regimens in highly drug-experienced HIV-1-infected patients.

Sabin CA, Wilkins E, Murphy M, Fisher M, de Ruiter A, Easterbrook PJ, Leen C, Vlahakis E, Cane PA, Li X, Pillay D; UK Expanded Access Amprenavir Programme. Sabin CA, et al. Among authors: pillay d. Antivir Ther. 2003 Aug;8(4):301-8. Antivir Ther. 2003. PMID: 14518699

9

Drug-resistant HIV-1 in the semen of men receiving antiretroviral therapy with acute sexually transmitted infections.

Taylor S, Sadiq ST, Weller I, Kaye S, Workman J, Cane PA, Bennett J, Copas AJ, Drake SM, Pillay D. Taylor S, et al. Among authors: pillay d. Antivir Ther. 2003 Oct;8(5):479-83. Antivir Ther. 2003. PMID: 14640396

10

The effect of highly active antiretroviral therapy for HIV on the anti-HCV specific humoral immune response.

Herrero-Martínez E, Sabin CA, Lee CA, Jones IM, Pillay D, Emery VC. Herrero-Martínez E, et al. Among authors: pillay d. J Med Virol. 2004 Feb;72(2):187-93. doi: 10.1002/jmv.10578. J Med Virol. 2004. PMID: 14695658

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

736 results

Search Page

Filters